Clinical Trial Update: KL-6 Protein as a Biomarker of Lung Injury in Viral Bronchiolitis

View source ↗

Summary

A clinical trial is investigating KL-6 protein as a biomarker of lung injury in acute viral bronchiolitis. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Bronchiolitis

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Acute Viral Bronchiolitis | Status: UNKNOWN